383
Views
0
CrossRef citations to date
0
Altmetric
Clinical

The natural history of ALS: Baseline characteristics from a multicenter clinical cohort

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , , , , , , , ORCID Icon, , , , , ORCID Icon, ORCID Icon & show all
Pages 625-633 | Received 03 Feb 2023, Accepted 26 Jun 2023, Published online: 17 Jul 2023

References

  • Quinn C, Elman L. Amyotrophic lateral sclerosis and other motor neuron diseases. Continuum (Minneap Minn). 2020;26:1323–47.
  • Logroscino G, Traynor BJ, Hardiman O, Chio’ A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
  • The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry 1992;55:536–41.
  • Mitchell JD, Gibson HN, Gatrell A. Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976-1986. A geographical study. 875. Arch Neurol. 1990;47:875–80.
  • Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. T504-509, s.l. Neurology 1999;52:504.
  • Register for Amyotrophic Lateral S. Incidence of ALS in Italy: evidence for a uniform frequency in Western countries Piemonte, Valle d’Aosta. Neurology 2001;56:239–44.
  • Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology 2007;68:141–45
  • Logroscino G, Beghi E, Zoccolella S, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. S.l.: J Neurol Neurosurg Psychiatry 2005;76:239–244.
  • Patients Like Me. [Online] [Cited: June 7, 2022.] https://www.patientslikeme.com/.
  • Miller RG, Anderson FA, Bradley WG, Brooks BR, Mitsumoto H, Munsat TL, et al. The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology 2000;54:53–53.
  • MOVR Data Hub. MOVR Data Hub (euromuscular ObserVational Research). [Online] [Cited: June 7, 2022.] https://www.mda.org/science/movr-data-hub-neuromuscular-observational-research.
  • Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, et al. The PRO-ACT database: design, initial analyses, and predictive features. Neurology 2014;83:1719–25.
  • Granit V, Grignon A‐L, Wuu J, Katz J, Walk D, Hussain S, et al. Harnessing the power of the electronic health record for ALS research and quality improvement: CreATe CAPTURE-ALS and the ALS Toolkit. Muscle and Nerve. 2022;65:154–61.
  • Barbalho I, Valentim R, Júnior MD, Barros D, Júnior HP, Fernandes F, et al. National registry for amyotrophic lateral sclerosis: a systematic review for structuring population registries of motor neuron diseases. BMC Neurol. 2021;21:269.
  • Zach N, Ennist DL, Taylor AA, Alon H, Sherman A, Kueffner R, et al. Being PRO-ACTive: what can a clinical trial database reveal about ALS? s.1: Neurotherapeutics. 2015;12:417–23.
  • Chiò A, Canosa A, Gallo S, Cammarosano S, Moglia C, Fuda G, et al. ALS clinical trials: do enrolled patients accurately represent the ALS population. Neurology 2011;77:1432–37.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (Phase III). J Neurol Sci. 1999;169:13–21.
  • Brooks BR, Miller R, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–299.
  • Mehta P, Raymond J, Punjani R, Larson T, Bove F, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 201623. s.l.: Amyotroph Lateral Scler Frontotemporal Degener. 2022; 23:220–25.
  • Sherman AV, Berry J, Gotkine M, Glass J, Lunetta C, Floeter MK, et al. PRO-ACE: Global Collaborative Ecosystem in a Post-PRO-ACT Era (P4.6-006). Neurology 2019;92:4.6–006.
  • Dettori JR. Loss to follow-up. 7. Evid Based Spine Care J. 2011;2:7–10.
  • Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 2009;72:725–731. s.l.: Vol.
  • Logroscino G, Marin B, Piccininni M, Arcuti S, Chiò A, Hardiman O, et al. Referral bias in ALS epidemiological studies. PLOS One. 2018;13:e0195821.
  • Stephens HE, Felgoise S, Young J, Simmons Z. Multidisciplinary ALS clinics in the USA: A comparison of those who attend and those who do not. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:196–201.
  • Andrews JA, Berry JD, Baloh RH, Carberry N, Cudkowicz ME, Dedi B, et al. Amyotrophic lateral sclerosis care and research in the United States during the COVID-19 pandemic: challenges and opportunities. Muscle Nerve. 2020;62:182–86.
  • de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–03. Epub 2007 Dec 27. PMID: 18164242.
  • Turner MR, UK MND Clinical Studies Group. Diagnosing ALS: the Gold Coast criteria and the role of EMG. Practical Neurology 2022;22:176–78.
  • Priorities of the NIH Amyotrophic Lateral Sclerosis (ALS) Strategic Planning Working Groups. National Institutes of Health. https://www.ninds.nih.gov/sites/default/files/documents/Draft%20ALS%20Strategic%20Plan_2022_11_16_508C.pdf; accessed 17 December 2022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.